Table 3. Relative Risk For Stroke And Stroke Subtypes in Relation to High-Density Lipoprotein Cholesterol Levels, Systematic Review and Meta-Analysis of Prospective Cohort Studies.
Study | Sex | Year | Relative Risk (95% CI)a | Weight (%)b |
---|---|---|---|---|
Total stroke | ||||
Watanabe et al (23) | Men and women | 2020 | 0.69 (0.50–0.95) | 6.12 |
Zhang et al (22) | Men and women | 2019 | 0.81 (0.67–0.96) | 19.49 |
Liu et al (21) | Men | 2019 | 0.86 (0.62–1.19) | 5.93 |
Liu et al (21) | Women | 2019 | 1.19 (0.73–1.94) | 2.64 |
Saito et al (10) | Men | 2017 | 0.75 (0.58–0.97) | 9.38 |
Saito et al (10) | Women | 2017 | 0.92 (0.71–1.19) | 9.34 |
Harandi et al (18) | Men and women | 2016 | 0.92 (0.63–1.34) | 4.43 |
Glasseret al (19) | Men and women | 2016 | 0.93 (0.78–1.10) | 21.24 |
Hirata et al (20) | Men and women | 2016 | 0.86 (0.38–1.93) | 0.95 |
Reina et al (9) | Men and women | 2015 | 0.56 (0.31–0.99) | 1.90 |
Tohidi et al (17) | Men and women | 2013 | 1.11 (0.44–2.78) | 0.74 |
Zhang et al (11) | Men | 2012 | 1.01 (0.66–1.53) | 3.60 |
Zhang et al (11) | Women | 2012 | 0.47 (0.30–0.74) | 3.21 |
Hamer et al (16) | Men and women | 2011 | 1.13 (0.75–1.68) | 3.88 |
Curb et al (8) | Men | 2004 | 0.20 (0.06–0.72) | 0.39 |
Soyama et al (7) | Men and women | 2003 | 0.48 (0.25–0.93) | 1.46 |
Simons et al (6) | Men and women | 2001 | 0.63 (0.42–0.95) | 3.83 |
Wannamethee et al (5) | Men | 2000 | 0.48 (0.25–0.93) | 1.46 |
Overallc | — | — | 0.82 (0.76–0.89) | 100.0 |
Ischemic stroke | ||||
Watanabe et al (23) | Men and women | 2020 | 0.76 (0.51–1.12) | 3.55 |
Gu et al (24) | Men and women | 2019 | 0.75 (0.67–0.83) | 10.89 |
Liu et al (21) | Men | 2019 | 0.83 (0.57–1.21) | 3.74 |
Liu et al (21) | Women | 2019 | 1.14 (0.67–1.93) | 2.21 |
Saito et al (10) | Men | 2017 | 0.68 (0.49–1.01) | 4.48 |
Saito et al (10) | Women | 2017 | 0.70 (0.49–1.01) | 3.98 |
Anne et al (41) | Men and women | 2017 | 0.78 (0.66–0.92) | 8.80 |
Glasser et al (19) | Men and women | 2016 | 0.88 (0.72–1.07) | 7.65 |
Hirata et al (20) | Men and women | 2016 | 1.15 (0.65–2.04) | 1.94 |
Pikula et al (42) | Men and women | 2015 | 0.51 (0.37–0.70) | 4.71 |
Tohidi et al (17) | Men and women | 2013 | 1.44 (0.54–3.84) | 0.73 |
Zhang et al (11) | Men | 2012 | 1.02 (0.62–1.66) | 2.47 |
Zhang et al (11) | Women | 2010 | 0.35 (0.21–0.59) | 2.29 |
Simons et al (45) | Men and women | 2010 | 1.10 (0.65–1.87) | 2.21 |
Willey et al (44) | Men and women | 2009 | 1.08 (0.67–1.66) | 2.80 |
Holme et al (47) | Men | 2009 | 0.79 (0.71–0.86) | 11.26 |
Holme et al (47) | Women | 2009 | 0.67 (0.59–0.73) | 10.91 |
Kurth et al (49) | Women | 2007 | 0.83 (0.53–1.30) | 2.90 |
Psaty et al (50) | Men and women | 2004 | 0.81 (0.60–1.10) | 4.90 |
Soyama et al (7) | Men and women | 2003 | 0.45 (0.21–1.00) | 1.09 |
Leppala et al (51) | Men | 1999 | 0.54 (0.39–0.75) | 4.49 |
Tanne et al (52) | Men | 1997 | 0.55 (0.31–0.93) | 2.04 |
Overalld | — | — | 0.75 (0.69–0.82) | 100.0 |
Intracerebral hemorrhage | ||||
Watanabe et al (23) | Men and women | 2020 | 0.59 (0.28–1.21) | 4.72 |
Rist et al (40) | Women | 2019 | 0.99 (0.47–2.09) | 4.53 |
Saito et al (10) | Men | 2017 | 0.79 (0.49–1.28) | 10.91 |
Saito et al (10) | Women | 2017 | 1.69 (1.05–2.73) | 11.01 |
Zhang et al (11) | Men | 2012 | 1.13 (0.41–3.07) | 2.51 |
Zhang et al (11) | Women | 2012 | 2.64 (0.67–10.42) | 1.34 |
Wieberdink et al (43) | Men and women | 2011 | 1.16 (0.84–1.61) | 23.91 |
Noda et al (46) | Men and women | 2009 | 1.19 (0.82–1.74) | 17.75 |
Sturgeon et al (48) | Men and women | 2007 | 1.69 (1.17–2.41) | 19.23 |
Leppala et al (51) | Men | 1999 | 1.08 (0.49–2.36) | 4.10 |
Overalle | — | — | 1.21 (1.04–1.42) | 100.0 |
Subarachnoid hemorrhage | ||||
Watanabe et al (23) | Men and women | 2020 | 0.64 (0.28–1.49) | 0.06 |
Rist et al (40) | Women | 2019 | 1.02 (0.35–2.97) | 0.04 |
Saito et al (10) | Men | 2017 | 1.53 (0.53–4.41) | 0.04 |
Saito et al (10) | Women | 2017 | 0.98 (0.96–1.00) | 99.79 |
Zhang et al (11) | Men | 2012 | 0.67 (0.19–2.35) | 0.03 |
Zhang et al (11) | Women | 2012 | 1.09 (0.24–4.91) | 0.02 |
Leppala et al (51) | Men | 1999 | 0.41 (0.14–1.23) | 0.03 |
Overallf | — | — | 0.98 (0.96–1.00) | 100.0 |
Abbreviation: —, not applicable.
subtypes per 1-mmol/L increase in high-density lipoprotein cholesterol
Weights are from random effects analysis.
I 2 = 42.9%; P = .03.
I 2 = 50.1%; P = .004.
I 2 = 33.4%; P = .14.
I 2 = 0.0%; P = .61.